天新药业：股东承诺延长股份锁定期6个月

Group 1 - The company Tianxin Pharmaceutical (603235) announced that its shareholders, Hou Ding Investment, Hou Sheng Investment, and Hou Tai Investment, voluntarily extended the lock-up period for their shares prior to the company's initial public offering by 6 months, until January 11, 2026 [1] - After the extension of the lock-up period, the restricted shares held by the aforementioned shareholders will be eligible for trading starting from January 12, 2026 [1]